MCID: SCR001
MIFTS: 41

Secretory Meningioma

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Secretory Meningioma

MalaCards integrated aliases for Secretory Meningioma:

Name: Secretory Meningioma 12 56 15 17 74
Meningioma 74

Classifications:



External Ids:

Disease Ontology 12 DOID:4588
MeSH 45 D008579
NCIt 51 C4718
SNOMED-CT 69 19453003

Summaries for Secretory Meningioma

MalaCards based summary : Secretory Meningioma, also known as meningioma, is related to meningioma, familial and spinal meningioma. An important gene associated with Secretory Meningioma is MUC1 (Mucin 1, Cell Surface Associated), and among its related pathways/superpathways are Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers and Cytoskeletal Signaling. The drugs Thrombin and Hemostatics have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and pituitary.

Related Diseases for Secretory Meningioma

Diseases related to Secretory Meningioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 131)
# Related Disease Score Top Affiliating Genes
1 meningioma, familial 10.4
2 spinal meningioma 10.4
3 malignant peritoneal mesothelioma 10.1 MUC1 VIM
4 papillary tumor of the pineal region 10.1 MUC1 VIM
5 syringocystadenoma papilliferum 10.1 MUC1 VIM
6 ossifying fibromyxoid tumor 10.1 MUC1 VIM
7 fibrous meningioma 10.1 MUC1 VIM
8 chordoid meningioma 10.1 MUC1 VIM
9 clear cell ependymoma 10.1 MUC1 VIM
10 ependymoma 10.1 MUC1 VIM
11 eccrine porocarcinoma 10.1 MUC1 VIM
12 endometrial mucinous adenocarcinoma 10.1 MUC1 VIM
13 biphasic synovial sarcoma 10.1 MUC1 VIM
14 adenofibroma 10.1 MUC1 VIM
15 clear cell meningioma 10.1 MUC1 VIM
16 myxopapillary ependymoma 10.1 MUC1 VIM
17 syringoma 10.1 MUC1 VIM
18 pleomorphic liposarcoma 10.1 MUC1 VIM
19 desmoplastic small round cell tumor 10.1 MUC1 VIM
20 perivascular epithelioid cell tumor 10.1 MUC1 VIM
21 anaplastic ependymoma 10.1 MUC1 VIM
22 reticulum cell sarcoma 10.1 MUC1 VIM
23 sertoli cell tumor 10.1 MUC1 VIM
24 intravascular papillary endothelial hyperplasia 10.1 SERPINA3 VIM
25 mesenchymal chondrosarcoma 10.1 MUC1 VIM
26 extraskeletal ewing sarcoma 10.1 MUC1 VIM
27 perineurioma 10.1 MUC1 VIM
28 epithelioid leiomyosarcoma 10.1 SERPINA3 VIM
29 chondroid chordoma 10.1 MUC1 VIM
30 dendritic cell tumor 10.1 MUC1 VIM
31 cutaneous fibrous histiocytoma 10.1 SERPINA3 VIM
32 fibrous histiocytoma 10.1 SERPINA3 VIM
33 cerebral primitive neuroectodermal tumor 10.1 MUC1 VIM
34 polymorphous low-grade adenocarcinoma 10.1 MUC1 VIM
35 hemangiopericytoma, malignant 10.1 MUC1 VIM
36 odontogenic myxoma 10.0 SERPINA3 VIM
37 granular cell tumor 10.0 SERPINA3 VIM
38 embryonal sarcoma 10.0 SERPINA3 VIM
39 cystadenocarcinoma 10.0 KRT7 MUC1
40 osteofibrous dysplasia 10.0 MUC1 VIM
41 solid adenocarcinoma with mucin production 10.0 KRT7 MUC1
42 endosalpingiosis 10.0 KRT7 MUC1
43 bile duct mucoepidermoid carcinoma 10.0 KRT7 MUC1
44 mucoepidermoid carcinoma 10.0 KRT7 MUC1
45 middle ear adenoma 10.0 KRT7 MUC1
46 cystadenoma 10.0 KRT7 MUC1
47 rhabdoid tumor predisposition syndrome 1 10.0 MUC1 VIM
48 mucinous adenocarcinoma 10.0 KRT7 MUC1
49 bile duct cystadenocarcinoma 10.0 KRT7 MUC1
50 bile duct adenoma 10.0 KRT7 MUC1

Graphical network of the top 20 diseases related to Secretory Meningioma:



Diseases related to Secretory Meningioma

Symptoms & Phenotypes for Secretory Meningioma

Drugs & Therapeutics for Secretory Meningioma

Drugs for Secretory Meningioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 272)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Thrombin Approved, Investigational Phase 4
2 Hemostatics Phase 4,Phase 3
3 Coagulants Phase 4,Phase 3
4 Fibrin Tissue Adhesive Phase 4
5
Tranexamic Acid Approved Phase 3 1197-18-8 5526
6
Progesterone Approved, Vet_approved Phase 3 57-83-0 5994
7
Mifepristone Approved, Investigational Phase 3 84371-65-3 55245
8
Donepezil Approved Phase 3,Phase 2,Early Phase 1 120014-06-4 3152
9
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
10
Ondansetron Approved Phase 3 99614-02-5 4595
11
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
12
Cisplatin Approved Phase 3,Phase 2 15663-27-1 2767 441203 84093
13
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 1 50-02-2 5743
14
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3,Phase 1 1177-87-3
15
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 3 7487-88-9 24083
16
Sevoflurane Approved, Vet_approved Phase 3 28523-86-6 5206
17
Cisatracurium Approved Phase 3 96946-41-7
18
Propofol Approved, Investigational, Vet_approved Phase 3 2078-54-8 4943
19
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
20
Dopamine Approved Phase 3 62-31-7, 51-61-6 681
21
Histamine Approved, Investigational Phase 3 51-45-6 774
22
Cyproheptadine Approved Phase 3 129-03-3 2913
23
Calcium Approved, Nutraceutical Phase 3,Phase 2,Phase 1 7440-70-2 271
24 Pancreatic Polypeptide Investigational Phase 3,Phase 1 59763-91-6
25 Antifibrinolytic Agents Phase 3
26 Gastrointestinal Agents Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
27 Dermatologic Agents Phase 3,Phase 2,Phase 1
28 Hormone Antagonists Phase 3,Phase 2,Phase 1,Not Applicable
29 Luteolytic Agents Phase 3
30 Contraceptives, Oral Phase 3
31 Hormones Phase 3,Phase 2,Phase 1,Not Applicable
32 glucocorticoids Phase 3,Phase 1
33 Contraceptives, Postcoital Phase 3
34 Contraceptive Agents Phase 3
35 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1,Not Applicable
36 Progestins Phase 3
37 Cholinesterase Inhibitors Phase 3,Phase 2,Early Phase 1
38 Neurotransmitter Agents Phase 3,Phase 2,Phase 1,Early Phase 1
39 Nootropic Agents Phase 3,Phase 2,Early Phase 1
40 Cholinergic Agents Phase 3,Phase 2,Early Phase 1
41 Narcotics Phase 3
42 Adjuvants, Anesthesia Phase 3
43 Analgesics Phase 3,Phase 2,Phase 1
44 Anesthetics, Intravenous Phase 3
45 Liver Extracts Phase 3,Phase 1,Phase 2
46 Anesthetics, General Phase 3
47 Anesthetics Phase 3,Not Applicable
48 Analgesics, Opioid Phase 3
49 Central Nervous System Depressants Phase 3,Phase 2,Phase 1,Not Applicable
50 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 195)
# Name Status NCT ID Phase Drugs
1 Cavernous Sinus Dissection and Bleeding in Meningiomas Unknown status NCT02863484 Phase 4
2 Phase IV Bioseal Study in Brain Tumor Surgery Completed NCT02034799 Phase 4
3 Neurocognitive Outcome Assesment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial. Not yet recruiting NCT03190122 Phase 4
4 SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors Unknown status NCT00517959 Phase 3
5 Efficacy of Tranexamic Acid in Brain Tumor Resections Unknown status NCT01655927 Phase 3 Tranexamic Acid;Placebo: Saline
6 S9005 Mifepristone in Meningioma Completed NCT03015701 Phase 3 Mifepristone
7 Proton/Photon Rt - Benign Meningiomas(P92-13) Completed NCT02947984 Phase 3
8 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
9 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
10 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
11 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery Recruiting NCT03180268 Phase 3
12 Magnesium and Intraoperative Blood Loss in Meningioma Surgery Not yet recruiting NCT03558516 Phase 3 Magnesium group;Normal saline group
13 Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery Terminated NCT00104936 Phase 3
14 Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors Terminated NCT00031798 Phase 3 methylphenidate hydrochloride
15 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
16 Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas Unknown status NCT02333565 Phase 2 Everolimus;Octreotide
17 Proton Radiation For Meningiomas and Hemangiopericytomas Unknown status NCT01117844 Phase 1, Phase 2
18 Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma Unknown status NCT00904735 Phase 2 hydroxyurea;imatinib mesylate
19 Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma Unknown status NCT00006119 Phase 2 hydroxyurea
20 Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas Unknown status NCT01024907 Phase 1, Phase 2
21 Monthly SOM230C for Recurrent or Progressive Meningioma Completed NCT00859040 Phase 2 SOM230C
22 Trabectedin for Recurrent Grade II/III Meningioma Completed NCT02234050 Phase 2 Trabectedin
23 S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma Completed NCT00003590 Phase 2 hydroxyurea
24 Combination of Hydroxyurea and Verapamil for Refractory Meningiomas Completed NCT00706810 Phase 2 Hydroxyurea;Verapamil
25 Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas Completed NCT00002965 Phase 2
26 Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma Completed NCT00626730 Phase 2
27 Imatinib Mesylate in Treating Patients With Recurrent Meningioma Completed NCT00045734 Phase 2 imatinib mesylate
28 Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Completed NCT00589784 Phase 2 Sunitinib
29 Vatalanib in Treating Patients With Recurrent or Progressive Meningioma Completed NCT00348790 Phase 2 vatalanib
30 Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma Completed NCT00354913 Phase 2 hydroxyurea;imatinib mesylate
31 Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma Completed NCT00010049 Phase 1, Phase 2 imatinib mesylate
32 Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma Completed NCT00045110 Phase 1, Phase 2 erlotinib hydrochloride
33 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
34 Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors Completed NCT00025675 Phase 2 gefitinib
35 Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 Completed NCT01419639 Phase 2 Everolimus (RAD001) , Afinitor®
36 Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) Completed NCT01207687 Phase 2
37 Irinotecan in Treating Children With Refractory Solid Tumors Completed NCT00004078 Phase 2 irinotecan hydrochloride
38 Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy Completed NCT00463203 Phase 2 Bevacizumab;Irinotecan
39 Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors Completed NCT01032200 Phase 2 Armodafinil
40 Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors Completed NCT00629889 Phase 2 levetiracetam;pregabalin
41 Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma Completed NCT00006102 Phase 2 becatecarin
42 Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors Completed NCT00005955 Phase 2 temozolomide
43 SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy Completed NCT00004868 Phase 1, Phase 2 semaxanib
44 Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor Completed NCT00070161 Phase 2 donepezil hydrochloride
45 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors Completed NCT00003461 Phase 1, Phase 2
46 Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer Completed NCT00014573 Phase 2 carmustine;cisplatin;cyclophosphamide;paclitaxel
47 Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Completed NCT00973739 Phase 2 Lapatinib
48 Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas Recruiting NCT03071874 Phase 2 AZD2014
49 Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma Recruiting NCT03279692 Phase 2 Pembrolizumab
50 A Study of Nivolumab in Adult Participants With Recurrent High-Grade Meningioma Recruiting NCT02648997 Phase 2 Nivolumab

Search NIH Clinical Center for Secretory Meningioma

Genetic Tests for Secretory Meningioma

Anatomical Context for Secretory Meningioma

MalaCards organs/tissues related to Secretory Meningioma:

42
Brain, Bone, Pituitary, Spinal Cord, T Cells, Endothelial, Prostate

Publications for Secretory Meningioma

Articles related to Secretory Meningioma:

(show top 50) (show all 3018)
# Title Authors Year
1
Contiguous Metastasis of Pulmonary Adenocarcinoma to Meningioma. ( 30321884 )
2019
2
Whole-tumor histogram analysis of apparent diffusion coefficient in differentiating intracranial solitary fibrous tumor/hemangiopericytoma from angiomatous meningioma. ( 30777209 )
2019
3
Application of Dextroscope in a Rare Type of Angiomatous Meningioma Characterized With Coral-Like Vessels. ( 30946223 )
2019
4
Delayed Dural Arteriovenous Fistula at the Transverse-Sigmoid Sinus Secondary to Petroclival Meningioma Surgery Via Far Lateral Approach. ( 31022135 )
2019
5
A rare case of diffuse intracranial aspergillosis masquerading as skull base meningioma in an immunocompetent patient. ( 30232959 )
2019
6
Challenging the concept that late recurrence and death from tumor are common after fractionated radiotherapy for benign meningioma. ( 31071515 )
2019
7
Transplantation of human meningioma stem cells loaded on a self-assembling peptide nanoscaffold containing IKVAV improves traumatic brain injury in rats. ( 31075516 )
2019
8
Prevalence of hitherto unknown brain meningioma detected on 68Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of 177Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors. ( 31040748 )
2019
9
Management of Cavernous Sinus Meningioma Presenting With Cerebrovascular Insufficiency Secondary to Cavernous Carotid Artery Occlusion: Report of 2 Cases. ( 29850864 )
2019
10
Meningioma Screening With MRI in Childhood Leukemia Survivors Treated With Cranial Radiation. ( 30880270 )
2019
11
Spinal Clear Cell Meningioma: Clinical Study with Long-Term Follow-Up in 12 Patients. ( 30342264 )
2019
12
Large falcine meningioma presented as treatment-resistant depression: A case report. ( 30846670 )
2019
13
Endoscopic Endonasal Focal Transclival-Medial Condylectomy Approach for Resection of a Foramen Magnum Meningioma: 2-Dimensional Operative Video. ( 29893955 )
2019
14
Serum Levels of APRIL Increase in Patients with Glioma, Meningioma and Schwannoma ( 30909681 )
2019
15
Glioma Simultaneously Present with Adjacent Meningioma: Case Report and Literature Review. ( 30937052 )
2019
16
Cluster-Like Headache Secondary to Anamnesis of Sphenoid Ridge Meningioma: A Case Report and Literature Review. ( 30740086 )
2019
17
Pre- and postoperative headache in patients with meningioma. ( 30089403 )
2019
18
Large dural-based mass with bony hyperostosis in a 16-year-old male: IgG4-related disease mimicking lymphoplasmacyte-rich meningioma. ( 31073682 )
2019
19
Idiopathic Hypertrophic Pachymeningitis Mimicking Meningioma with Occlusion of Superior Sagittal Sinus: Case Report and Review of Literature. ( 30965168 )
2019
20
Intraventricular Meningioma Presenting As Lateral Posterior Choroidal Artery Stroke. ( 30822588 )
2019
21
Editors' note: Lymphoplasmacyte-rich meningioma involving the whole intracranial dura mater. ( 30833477 )
2019
22
Reader response: Lymphoplasmacyte-rich meningioma involving the whole intracranial dura mater. ( 30833478 )
2019
23
Author response: Lymphoplasmacyte-rich meningioma involving the whole intracranial dura mater. ( 30833479 )
2019
24
Giant Olfactory Groove Meningioma-2-Staged Approach: 2-Dimensional Operative Video. ( 29669134 )
2019
25
Optic nerve sheath meningioma. ( 30054955 )
2019
26
Visual Outcomes of Fractionated Radiotherapy in Optic Nerve Sheath Meningioma: A Retrospective Study. ( 30812038 )
2019
27
Non secretory Paraganglioma in cavernous sinus masquerading as meningioma. ( 30831293 )
2019
28
Skull Vault Plasmacytoma Mimicking Parasagittal Meningioma: "Mini-Brain Appearance". ( 30937041 )
2019
29
Endovascular stenting of the superior sagittal sinus to alleviate venous compression caused by a parasagittal meningioma. ( 30954959 )
2019
30
Susceptibility-Weighted Imaging of Deep Venous Congestion in Petroclival Meningioma. ( 30236813 )
2019
31
Preservation of Venous Drainage in Middle Fossa During Combined Transpetrosal Approach for Petroclival Meningioma. ( 30529519 )
2019
32
Petroclival Meningioma Presenting With an Ipsilateral Sixth Nerve Palsy and a Contralateral Homonymous Quadrantanopia: A Unique and Topographically Localizing Syndrome. ( 30664101 )
2019
33
The Retrosigmoid Approach: Workhorse for Petroclival Meningioma Surgery. ( 30937033 )
2019
34
A comprehensive study of risk factors for post-operative pneumonia following resection of meningioma. ( 30674295 )
2019
35
Neurogenic Pulmonary Edema and Stunned Myocardium in a Patient With Meningioma: A Heart-Brain Cross Talk. ( 29432276 )
2019
36
Large left posterior fossa meningioma presenting with quadriplegia in a woman with history of carbidopa-levodopa resistant parkinsonism. ( 30996844 )
2019
37
New-onset psychiatric symptoms following intracranial meningioma in a patient with schizophrenia: a case study. ( 30758462 )
2019
38
Secretory meningioma with bone infiltration and orbital spreading. ( 30957470 )
2019
39
Placement of cesium-131 permanent brachytherapy seeds using the endoscopic endonasal approach for recurrent anaplastic skull base meningioma: case report and technical note. ( 30835687 )
2019
40
EQ-5D Quality-of-Life Analysis and Cost-Effectiveness After Skull Base Meningioma Resection. ( 30869135 )
2019
41
Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma. ( 30953136 )
2019
42
Spinal Meningiomas Prognostic Evaluation Score (SPES): predicting the neurological outcomes in spinal meningioma surgery. ( 29516306 )
2019
43
Treatment outcomes of 17 patients with atypical spinal meningioma, including 4 with metastases: a retrospective observational study. ( 29906618 )
2019
44
Posterior Cervical Laminoplasty for Resection Intradural Extramedullary Spinal Meningioma: 2-Dimensional Operative Video. ( 30107430 )
2019
45
Spontaneous Hemorrhage followed by paraparesis in a patient with a Spinal Meningioma. ( 30684702 )
2019
46
Magnetic resonance imaging spectrum of spinal meningioma. ( 30802771 )
2019
47
Scalp BCC's and meningioma following X-ray epilation for tinea capitis. ( 30378096 )
2019
48
Proposed Treatment for Intracranial Transitional Meningioma: A Single-Center Series of 298 Cases. ( 30902770 )
2019
49
Combined multi-portal endoscopic endo-nasal and transcranial approach for a recurrent tuberculum sellae meningioma: operative video. ( 30974272 )
2019
50
Neurofibromatosis type 2 gene mutation and progesterone receptor messenger RNA expression in the pathogenesis of sporadic orbitocranial meningioma. ( 31024808 )
2019

Variations for Secretory Meningioma

Expression for Secretory Meningioma

Search GEO for disease gene expression data for Secretory Meningioma.

Pathways for Secretory Meningioma

Pathways related to Secretory Meningioma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.38 KLF4 VIM
2 11.29 KRT7 MUC1 VIM
3 11.21 MUC1 VIM
4
Show member pathways
10.99 KRT7 VIM

GO Terms for Secretory Meningioma

Cellular components related to Secretory Meningioma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 8.92 KRT7 MUC1 SERPINA3 VIM

Sources for Secretory Meningioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....